ArticleGut and liver2026
In-Hospital Hepatitis C Alarm System: A Strategy to Enhance Linkage to Care for Hepatitis C Virus Infection.
Article in Gut and liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: The World Health Organization aims to eliminate hepatitis C virus (HCV) by 2030; however, linkage to care rates remain suboptimal. To address this, an in-hospital HCV alarm system integrated into electronic medical records (EMRs) was implemented to increase confirmatory testing and referral rates. Methods: This retrospective study analyzed patients with positive anti-HCV antibody results at a tertiary hospital in Korea, comparing the pre-alarm period (August 2020-July 2022) with the post-alarm period (July 2022-May 2024). HCV RNA testing rates, liver clinic visits, and direct-acting antiviral (DAA) prescriptions were assessed. Multivariate logistic regression was performed to identify factors associated with the lack of HCV RNA testing implementation. Results: Among 941 patients who tested positive for anti-HCV antibodies, the proportion of patients who underwent HCV RNA testing significantly increased from 49.4% in the pre-alarm period to 67.8% in the post-alarm period (p<0.001). The rate of referral to liver specialists also showed an increasing trend (89.4% vs 93.2%), while DAA initiation rates remained similar (68.4% vs 72.0%). Multivariate analysis revealed that older age, surgical or emergency department admission, and non-liver-related testing indications were independent predictors of the lack of HCV RNA testing implementation. Conclusions: Implementation of an in-hospital HCV alarm system significantly increased HCV RNA testing rates, enhancing early diagnosis and linkage to care. While referral rates remained high, persistently low testing rates in emergency departments highlight the need for targeted interventions. A cost-effective, EMR-integrated alarm system may be a feasible strategy to support national HCV elimination efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.